Oncotelic closes $1.0M debt-to-equity conversion; issues 40 Units with notes and warrants

Oncotelic Therapeutics, Inc.

Converted $1.0M of debt via private placement of 40 Units to accredited investors.
Each Unit: $25K convertible note (16% interest, 2-yr, $0.10 conversion) and 250K warrants at $0.12/share.
Total offering up to 200 Units ($5M); placement agent JH Darbie, $150K fees paid.
Securities unregistered, exempt under Rule 506(b); Registration Rights Agreement filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.